These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 807702)

  • 61. The role of topical dimethyl sulfoxide in burn wound infection: evaluation in the rat.
    Raskin DJ; Sullivan KH; Rappaport NH
    Ann N Y Acad Sci; 1983; 411():105-9. PubMed ID: 6576686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topical use of silver sulphadiazine and chlorhexidine in the prevention of infection in thermal injuries.
    Clarke AM
    Med J Aust; 1975 Mar; 1(13):413-5. PubMed ID: 806768
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The local effect of a silver chelate on standardized scald wounds of the rat].
    Springorum HW; Bertram E; Köhnlein HE; Winckler S
    Arzneimittelforschung; 1975 Nov; 25(11):1782-3. PubMed ID: 812507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alternative forms of local treatment for burns.
    Lowbury EJ; Lilly HA; Cason JS; Jackson DM; Bull JP; Davies JW; Ford PM
    Lancet; 1971 Nov; 2(7734):1105-11. PubMed ID: 4107394
    [No Abstract]   [Full Text] [Related]  

  • 66. [Silver sulfadiazine (Flamazine). An antibacterial agent in the local prevention and therapy of burn wound infections].
    Hoffmann S
    Ugeskr Laeger; 1984 Jul; 146(30):2250-2. PubMed ID: 6515819
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study.
    Helvig EI; Munster AM; Su CT; Oppel W
    Am Surg; 1979 Apr; 45(4):270-2. PubMed ID: 434623
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of wound healing activities of kefir products.
    Huseini HF; Rahimzadeh G; Fazeli MR; Mehrazma M; Salehi M
    Burns; 2012 Aug; 38(5):719-23. PubMed ID: 22237053
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
    Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
    J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparative study of the dressings silver sulfadiazine and Aquacel Ag in the management of superficial partial-thickness burns.
    Yarboro DD
    Adv Skin Wound Care; 2013 Jun; 26(6):259-62. PubMed ID: 23685525
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Bacteriostatic effects of silver norfloxacin, silver sulfadiazine, and "moisture burn ointment"].
    Liao WZ
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 May; 9(3):184-5. PubMed ID: 8402351
    [No Abstract]   [Full Text] [Related]  

  • 74. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A ten-year retrospective study of sepsis in severely burned patients treated with or without silver sulfadiazinate.
    Micheels J; Moray V; Castermans A
    Scand J Plast Reconstr Surg; 1979; 13(1):85-7. PubMed ID: 451485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings.
    Robb EC; Fitz DG; Nathan P
    Trans Am Soc Artif Intern Organs; 1980; 26():533-6. PubMed ID: 6787772
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
    Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
    Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of burn sepsis with special reference to Pseudomonas aeruginosa.
    Nagesha CN; Shenoy KJ; Chandrashekar MR
    J Indian Med Assoc; 1996 Jun; 94(6):230-3. PubMed ID: 8979681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections.
    Arora SK; Neely AN; Blair B; Lory S; Ramphal R
    Infect Immun; 2005 Jul; 73(7):4395-8. PubMed ID: 15972536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.